Ren-Yi Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ren-Yi Lu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Yan Wang
School of Pharmacy, Naval Medical University, Shanghai, China
2 shared publications - Dazhi Zhang
Department of Organic Chemistry, School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
1 shared publication - Hua Zhong
Second Military Medical University (Naval Medical University)
1 shared publication Jing Wu
School of Pharmacy, Second Military Medical University, Shanghai, People's Republic of China
1 shared publicationLan Yan
School of Pharmacy, Second Military Medical University, Shanghai, People's Republic of China
1 shared publication- Lei Han
School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
1 shared publication
Latest Publications
- 15 December 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 340, 119248
Anti-sepsis effects of Dahuang Mudan decoction and its disassembled prescriptions
- 15 December 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 340, 119248
Anti-sepsis effects of Dahuang Mudan decoction and its disassembled prescriptions
- Open Access
- 28 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 12 (1) , 48
Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
Fungal infections have become a growing public health challenge due to the clinical transmission of pathogenic fungi. The currently available antifungal drugs leave very limited choices for clinical physicians to deal with such situation, not to mention the long-standing problems of emerging drug resistance, side effects and heavy economic burdens imposed to patients. Therefore, new antifungal drugs are urgently needed. Screening drugs from natural products and using synthetic biology strategies are very promising for antifungal drug development. Chinese medicine is a vast library of natural products of biologically active molecules. According to traditional Chinese medicine (TCM) theory, preparations used to treat fungal diseases usually have antifungal and immunomodulatory functions. This suggests that if antifungal drugs are used in combination with immunomodulatory drugs, better results may be achieved. Studies have shown that the active components of TCM have strong antifungal or immunomodulatory effects and have broad application prospects. In this paper, the latest research progress of antifungal and immunomodulatory components of TCM is reviewed and discussed, hoping to provide inspiration for the design of novel antifungal compounds and to open up new horizons for antifungal treatment strategies.
- 28 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 12 (1) , 48
Open AccessAntifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
Fungal infections have become a growing public health challenge due to the clinical transmission of pathogenic fungi. The currently available antifungal drugs leave very limited choices for clinical physicians to deal with such situation, not to mention the long-standing problems of emerging drug resistance, side effects and heavy economic burdens imposed to patients. Therefore, new antifungal drugs are urgently needed. Screening drugs from natural products and using synthetic biology strategies are very promising for antifungal drug development. Chinese medicine is a vast library of natural products of biologically active molecules. According to traditional Chinese medicine (TCM) theory, preparations used to treat fungal diseases usually have antifungal and immunomodulatory functions. This suggests that if antifungal drugs are used in combination with immunomodulatory drugs, better results may be achieved. Studies have shown that the active components of TCM have strong antifungal or immunomodulatory effects and have broad application prospects. In this paper, the latest research progress of antifungal and immunomodulatory components of TCM is reviewed and discussed, hoping to provide inspiration for the design of novel antifungal compounds and to open up new horizons for antifungal treatment strategies.
- Open Access
- 27 January 2020
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (2)
New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans In Vitro and In Vivo
In the past decades, the incidence of cryptococcosis has increased dramatically, which poses a new threat to human health. However, only a few drugs are available for the treatment of cryptococcosis. Here, we described a leading compound, NT-a9, an analogue of isavuconazole, that showed strong antifungal activities in vitro and in vivo .
- 27 January 2020
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (2)
Open AccessNew Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans In Vitro and In Vivo
In the past decades, the incidence of cryptococcosis has increased dramatically, which poses a new threat to human health. However, only a few drugs are available for the treatment of cryptococcosis. Here, we described a leading compound, NT-a9, an analogue of isavuconazole, that showed strong antifungal activities in vitro and in vivo .